BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

BANK OF AMERICA CORP /DE/'s Holding History (CIK: 0000070858)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,583,000 Value ($000) $4,022 Avg Close — Range —
Q3 2025
Shares 10,000 Value ($000) $10 Avg Close — Range —
Q2 2025
Shares 703,000 Value ($000) $654 Avg Close — Range —
Q1 2025
Shares 12,453,000 Value ($000) $11,164 Avg Close — Range —
Q4 2024
Shares 10,967,000 Value ($000) $9,355 Avg Close — Range —
Q3 2024
Shares 10,467,000 Value ($000) $8,740 Avg Close — Range —
Q2 2024
Shares 17,889,000 Value ($000) $14,165 Avg Close — Range —
Q1 2024
Shares 11,929,000 Value ($000) $9,714 Avg Close — Range —
Q4 2023
Shares 7,981,000 Value ($000) $6,759 Avg Close — Range —
Q3 2023
Shares 10,597,000 Value ($000) $7,895 Avg Close — Range —
Q2 2023
Shares 5,699,000 Value ($000) $3,499 Avg Close — Range —
Q1 2023
Shares 6,199,000 Value ($000) $3,951 Avg Close — Range —
Q4 2022
Shares 4,649,000 Value ($000) $1,729 Avg Close — Range —
Q3 2022
Shares 4,649,000 Value ($000) $2,016 Avg Close — Range —
Q2 2022
Shares 3,149,000 Value ($000) $1,287 Avg Close — Range —
Q1 2022
Shares 3,149,000 Value ($000) $1,458 Avg Close — Range —